Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-27

Clinical Trial Update: 2 Arm Study of Clofarabine IV in MDS Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous Clofarabine in patients with myelodysplastic syndrome and leukemia has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clolar (Clofarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-07-27